BPC-157: Scientific History, Structure, and Published Research
Discovery and Origins
Body Protection Compound-157 (BPC-157) is a synthetic pentadecapeptide consisting of 15 amino acids (sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) with a molecular weight of approximately 1419 Da. It was first isolated as a partial sequence from human gastric juice by Professor Predrag Sikiric and colleagues at the University of Zagreb in the early 1990s. Unlike many synthetic peptides derived from recombinant or fully synthetic origins, BPC-157 is unique in that its parent sequence occurs naturally in gastric secretions.
Chemical Structure and Properties
BPC-157 is a linear pentadecapeptide with no disulfide bonds, contributing to its notable stability across a wide pH range (pH 2–12). This acid stability is unusual among bioactive peptides and has made BPC-157 a particularly useful tool compound in cell culture studies involving variable acidic conditions. The peptide is supplied in lyophilized form as a white to off-white powder, soluble in water and most aqueous buffers.
The absence of cysteine or methionine residues in the sequence also reduces susceptibility to oxidative degradation, contributing to favorable storage characteristics compared to many other research peptides.
Mechanism of Action: Published In Vitro and Preclinical Data
BPC-157 has been the subject of over 100 peer-reviewed publications examining multiple signaling pathways:
Nitric Oxide (NO) System
Published studies have demonstrated BPC-157 modulation of both constitutive endothelial nitric oxide synthase (eNOS) and inducible nitric oxide synthase (iNOS) expression in cell models. The NO system plays a central role in vascular biology, and BPC-157's interaction with this pathway has been a major area of investigation.
Angiogenesis and VEGF Signaling
In vitro studies using endothelial cell models have shown that BPC-157 promotes vascular endothelial growth factor (VEGF) expression and tube formation in matrigel assays. This has made it relevant to research in angiogenic signaling cascades.
FAK-Paxillin Pathway
Research has examined BPC-157's influence on focal adhesion kinase (FAK) and paxillin phosphorylation, components of the integrin-mediated cell migration and adhesion signaling cascade. These studies utilized fibroblast and tendon-derived cell lines.
GABAergic System
Preclinical studies have investigated interactions between BPC-157 and the gamma-aminobutyric acid (GABA) neurotransmitter system, including modulation of GABAergic transmission in various experimental models.
Key Published Studies
- Chang CH et al. (2011) — Examined BPC-157 effects on tendon fibroblast outgrowth, migration, and type I collagen expression in cell culture.
- Staresinic M et al. (2010) — Investigated BPC-157 in rat tendon transection models examining collagen fiber organization.
- Vukojevic J et al. (2020) — Studied BPC-157 in spinal cord injury models in rats.
Future Research Outlook
BPC-157 remains one of the most actively studied research peptides. Current directions include further characterization of its receptor binding profile (no definitive primary receptor has been identified), investigation of its interaction with the dopaminergic system, and structure-activity relationship (SAR) studies examining which residues are essential for biological activity. The peptide's remarkable pH stability continues to make it attractive for gastrointestinal cell culture models.
Crush Research supplies BPC-157 in 5mg and 10mg vial formats, each lot independently verified by third-party HPLC, MS, and endotoxin testing with published Certificates of Analysis.
All products are intended for in vitro and laboratory research use only. Not for human or veterinary use.